Lisa Gillen

Exposure‐Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice

Maria Luisa Veronese, Lisa Gillen, Joanne Burke et al. · The Journal of Clinical Pharmacology · 2003 · 147 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174

Jacqueline B. McCrea, Alastair E. Cribb, Tom Rushmore et al. · Clinical Pharmacology & Therapeutics · 1999 · 73 citations

Medicine, Biochemistry, Pharmacology +7

A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.

Howard Greenberg, Keith Gottesdiener, Martha Huntington et al. · PubMed · 2000 · 69 citations

Medicine, Pharmacology, Clinical Pharmacology +14

Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as In Vivo Probes for CYP3A Activity

Jacqueline B. McCrea, Thomayant Prueksaritanont, Barry J. Gertz et al. · The Journal of Clinical Pharmacology · 1999 · 57 citations

Medicine, Pharmacokinetics, Pharmacology +8

A New Cyclooxygenase‐2 Inhibitor, Rofecoxib (VIOXX®), Did Not Alter the Antiplatelet Effects of Low‐Dose Aspirin in Healthy Volunteers

Howard Greenberg, Keith Gottesdiener, Martha Huntington et al. · The Journal of Clinical Pharmacology · 2000 · 37 citations

Medicine, Pharmacology, Clinical Pharmacology +10